Related Experiment Video
Updated: Jul 17, 2026

COVID-19 Seroprevalence Test for IgG Antibody Levels Among Healthy Donors Across Different Pandemic Phases in Jeddah
Published on: June 24, 2025
Tuberculin test conversion among employees of a tertiary care hospital in Riyadh, Saudi Arabia
1Department of Family Medicine and Polyclinics, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
Background:
The objective of this study was to determine the tuberculin skin test conversion rate, as well as the course and outcome of the converters, among employees of a tertiary care hospital. The study is a retrospective, cohort descriptive study undertaken at the King Faisal Specialist Hospital and Research Centre, in Riyadh, Saudi Arabia.
Patients And Methods:
The study was undertaken over a four-year period from 1993 to 1996, and the subjects were employees who had annual screening PPD skin tests. The outcome measures skin test conversion, prophylactic treatment with isoniazid (INH), side effects, and development of clinical tuberculosis.
Results:
A total of 6883 tuberculin skin tests were performed during the study period. The mean annual conversion rate was 1.55%. About 78% of the converters received INH prophylaxis, but only 75% of those who started chemoprophylaxis completed the course. The side effects of INH treatment were found in 23% of those on treatment, and one of the converters developed clinically active tuberculosis during the study period.
Conclusion:
At the King Faisal Specialist Hospital and Research Centre, the mean annual tuberculin skin test conversion rate among employees is similar to that found in other studies, but compliance to oral isoniazide prophylaxis is low. There is a need to develop strategies to improve compliance.
Related Concept Videos
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...